share_log

通化金马(000766.SZ):研制的琥珀八氢氨吖啶片主要用于治疗轻、中度阿尔茨海默病

Tonghua Golden-Horse Pharmaceutical Industry Co., Ltd. (000766.SZ) developed Amber tinapentine hydrochloride tablets mainly for the treatment of mild to moderate Alzheimer's disease.

Gelonghui Finance ·  Jul 29 03:51

On July 29, Gelunhui reported that Tonghua Golden-Horse Pharmaceutical Industry Co., Ltd. (SZ 000766) stated on the investor interaction platform that their research on Amber Octahydroaminoacridine tablets is mainly used to treat mild to moderate Alzheimer's disease.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment